Related Experiment Video
Updated: Jun 24, 2026
06:02
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
[Cholesterol and statins in Alzheimer disease]
1Neurologisch-psychiatrische Abteilung, Allgemeines Krankenhauses der Stadt Linz, Krankenhausstrasse 9, A-4020 Linz. gerhard.ransmayr@akh.linz.at
Wiener Medizinische Wochenschrift (1946)
|July 26, 2003
Summary
Statins may reduce Alzheimer's disease risk by 60-73%. Research suggests statins could offer a protective effect against Alzheimer's disease by influencing brain cholesterol and protein levels.
Area of Science:
- Neuroscience
- Pharmacology
- Genetics
Background:
- Observational studies indicate statins may reduce Alzheimer's disease (AD) prevalence by 60-73%.
- A CYP46 gene polymorphism (cholesterol-24 hydroxylase) is linked to increased late-onset AD risk.
Purpose of the Study:
- To investigate the potential prophylactic effect of statins on Alzheimer's disease incidence.
- To explore the mechanisms by which statins might impact cerebral cholesterol turnover and AD pathology.
Main Methods:
- Review of existing observational studies on statin use and AD prevalence.
- Analysis of genetic studies linking CYP46 gene polymorphism to AD risk.
- Discussion of statin's blood-brain barrier penetration and effects on cerebral cholesterol metabolism.
Main Results:
- Statins show a significant reduction (60-73%) in observed Alzheimer's disease prevalence.
- CYP46 gene variations correlate with a higher risk of developing late-onset Alzheimer's disease.
- Statins may modulate cerebrospinal fluid (CSF) tau and amyloid-beta (Aβ) concentrations.
Conclusions:
- Statins present a potential preventative strategy for Alzheimer's disease.
- Further research is needed to identify optimal statins for reducing cerebral amyloid metabolism.
- Investigating statins' efficacy in lowering Alzheimer's disease severity is warranted.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...